Abbott Again Goes After Sandoz Over Generic Zemplar

Law360, New York (July 2, 2012, 6:46 PM EDT) -- Abbott Laboratories on Friday renewed its efforts to protect its Zemplar kidney disease drug, launching a lawsuit in Delaware federal court in which Sandoz Inc. is once again accused of infringing Abbott's patents by trying to introduce a generic version of the drug.

Abbott and partner Wisconsin Alumni Research Foundation allege that Sandoz is infringing a pair of their patents by attempting to bring to market a generic version of Zemplar in capsule form, the third such suit the companies have brought against the generics maker....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.